Mebane Nova B, Wells Rosemary E, Bevinal Manzoor
Internal Medicine, Corpus Christi Medical Center, Corpus Christi, USA.
Internal Medicine, Texas College of Osteopathic Medicine, Fort Worth, USA.
Cureus. 2023 Oct 6;15(10):e46582. doi: 10.7759/cureus.46582. eCollection 2023 Oct.
Hepatocellular carcinoma (HCC) is the most common primary liver tumor. Most patients present to the hospital with systemic symptoms and typically have a history of liver disease. This case study involves a male in his 60s who presented to our hospital facility with a chief complaint of abdominal pain. He reported no history of liver disease but was diagnosed with HCC stage IVB during this hospitalization. Upon further imaging, a tumor thrombus was found invading the inferior vena cava with an extension into the right atrium. Our primary learning point in this article is to emphasize the importance of prompt surveillance for primary care physicians with patients who are at increased risk for HCC. Additionally, we discuss specific management aimed toward patients diagnosed with a tumor thrombus extending into the right atrium. This management includes dual immunotherapy (atezolizumab and bevacizumab) and transarterial chemotherapy embolization (TACE).
肝细胞癌(HCC)是最常见的原发性肝脏肿瘤。大多数患者就医时伴有全身症状,且通常有肝脏疾病史。本病例研究涉及一名60多岁的男性,他因腹痛为主诉前来我院就诊。他报告无肝脏疾病史,但在此次住院期间被诊断为IVB期肝细胞癌。进一步影像学检查发现肿瘤血栓侵犯下腔静脉并延伸至右心房。本文的主要学习要点是强调基层医疗医生对肝细胞癌高危患者进行及时监测的重要性。此外,我们还讨论了针对诊断为肿瘤血栓延伸至右心房患者的具体治疗方法。这种治疗方法包括双重免疫疗法(阿替利珠单抗和贝伐单抗)和经动脉化疗栓塞术(TACE)。